Targeting EBV is a viable therapeutic strategy in MS: No

Funding The author received no financial support for the research, authorship, and/or publication of this article.

Authors

Institutions

Publication Details

Journal
Multiple Sclerosis Journal
Published
2026-01-14
DOI
https://doi.org/10.1177/13524585251409970
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting EBV is a viable therapeutic strategy in MS: No

Niels Hellings
Multiple Sclerosis Journal
Multiple Sclerosis Research Studies
article

Targeting EBV is a viable therapeutic strategy in MS: No

Niels Hellings
article en

Abstract

Funding The author received no financial support for the research, authorship, and/or publication of this article.

Multiple Sclerosis Journal
Hasselt University (BE)
Openalex Percentile: Top 89%
Multiple Sclerosis Research Studies
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.